COGT Cogent Biosciences, Inc. - Common Stock
$37.62
价格 · 八月 19, 2026
截至...的财报数据 八月 10, 2026
52周区间
$12–$44
81% of range
分析师评级
STRONG BUY
19 analysts
目标价
$54
+43% upside
P/E (TTM)
-17.4
ROE
-83.1%
净利润率
—
COGT 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$37.62
市值
$6.06B
P/E (TTM)
-17.4
每股收益 (TTM)
$-2.16
营收 (TTM)
—
股息收益率
—
ROE
-83.1%
负债/权益
—
52周区间
$12 – $44
COGT 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
2017-12-31
→
2020-12-31
EPS
$-2.16
2021-12-31
→
2025-12-31
自由现金流
$-266M
2018-12-31
→
2025-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
COGT
同行中位数
P/E (TTM)
-17.4
16.0
P/S (TTM) (市销率 (TTM))
261.5
47.5
P/B (市净率)
9.5
8.5
Price / FCF (股价/自由现金流)
-22.8
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
COGT
同行中位数
ROA
-52.0%
-45.0%
ROE
-83.1%
-86.5%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
COGT
同行中位数
Current Ratio (流动比率)
14.2
5.8
Quick Ratio (速动比率)
4.9
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
COGT
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
COGT
同行中位数
COGT 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
19 位分析师
- 强烈买入 8 42.1%
- 买入 8 42.1%
- 持有 3 15.8%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
12 位分析师 · 2026-08-16
中位数
$55.00
现在
$37.62
最低
$35.00
最高
$62.00
中位数目标
$55.00
+46.2%
平均目标
$53.83
+43.1%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.01%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年3月31日 | $-0.60 | $-0.55 | -0.05% |
| 2025年12月31日 | $-0.64 | $-0.53 | -0.11% |
| 2025年9月30日 | $-0.50 | $-0.54 | 0.04% |
| 2025年6月30日 | $-0.53 | $-0.60 | 0.07% |
| 2025年3月31日 | $-0.52 | $-0.60 | 0.08% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| COGT | $5.72B | -16.4 | — | — | -83.1% | — |
| ORKA | $1.48B | -3.3 | — | — | -25.9% | — |
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | — |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | — |
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| SRRK | $4.78B | -13.4 | — | — | -157.9% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $8M | $22M | $10M | $8M | |
| R&D Expense | $270M | $233M | $174M | $122M | $56M | $26M | $44M | $38M | $30M | |
| SG&A Expense | $64M | $43M | $34M | $26M | $20M | $17M | $11M | $7M | $5M | |
| Operating Expenses | $333M | $276M | $208M | $148M | $76M | $90M | $55M | $46M | $35M | |
| Operating Income | $-333M | $-276M | $-208M | $-148M | $-76M | $-82M | $-32M | $-36M | $-26M | |
| Interest Income | $15M | $18M | $13M | $4M | $467.0K | $144.0K | $267.0K | $1M | $386.0K | |
| Other Non-op | $-20.0K | $2M | $943.0K | $2M | $3M | $7M | $345.0K | $320.0K | $274.0K | |
| Income Tax | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-329M | $-256M | $-192M | $-140M | $-72M | $-75M | $-32M | $-35M | $-25M | |
| EPS (Basic) | $-2.16 | $-1.94 | $-1.94 | $-1.73 | $-1.87 | · | · | · | · | |
| EPS (Diluted) | $-2.16 | $-1.94 | $-1.94 | $-1.73 | $-1.87 | · | · | · | · | |
| Shares (Basic) | 128,899,408 | 103,856,611 | 79,657,942 | 58,739,713 | 38,730,813 | · | · | · | · | |
| Shares (Diluted) | 128,899,408 | 103,856,611 | 79,657,942 | 58,739,713 | 38,730,813 | · | · | · | · | |
| EBITDA | $-333M | $-276M | $-208M | $-148M | $-76M | $-82M | $-32M | $-36M | · |
资产负债表 22
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $312M | $98M | $53M | $140M | $220M | $242M | $37M | $56M | $28M | |
| Short-term Investments | · | · | · | · | · | · | · | $23M | $13M | |
| Receivables | · | · | · | · | · | · | $2M | $2M | $830.0K | |
| Prepaid Expense | $10M | $9M | $5M | $4M | $3M | $3M | $1M | $740.0K | $513.0K | |
| Current Assets | $910M | $296M | $271M | $265M | $223M | $245M | $41M | $81M | $42M | |
| PP&E (Net) | $5M | $6M | $8M | $8M | $2M | $134.0K | $2M | $3M | $4M | |
| PP&E (Gross) | $14M | $13M | $12M | $9M | $2M | $546.0K | $6M | $7M | $6M | |
| Accum. Depreciation | $9M | $6M | $4M | $1M | $559.0K | $412.0K | $5M | $3M | $2M | |
| Other Non-current Assets | $3M | $5M | $5M | $5M | $4M | · | $427.0K | $419.0K | · | |
| Total Assets | $938M | $328M | $313M | $301M | $232M | $251M | $49M | $86M | $49M | |
| Accounts Payable | $10M | $12M | $11M | $6M | $3M | $732.0K | $3M | $2M | $1M | |
| Current Liabilities | $64M | $56M | $38M | $27M | $17M | $13M | $13M | $25M | $11M | |
| Capital Leases | $14M | $16M | $17M | $18M | $831.0K | $3M | $4M | · | · | |
| Other Non-current Liabilities | $33.0K | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $301M | $72M | $56M | $45M | $18M | $16M | $18M | $26M | $21M | |
| Long-term Debt | $223M | · | · | · | · | · | · | · | · | |
| Common Stock | $161.0K | $110.0K | $86.0K | $70.0K | $44.0K | $32.0K | $8.0K | $30.0K | $10.0K | |
| Retained Earnings | $-1.19B | $-859M | $-604M | $-411M | $-271M | $-199M | $-124M | $-92M | $-51M | |
| AOCI | $355.0K | $447.0K | $246.0K | $-104.0K | · | · | · | $-12.0K | $-16.0K | |
| Stockholders' Equity | $636M | $256M | $258M | $256M | $214M | $235M | $32M | $60M | $-49M | |
| Liabilities + Equity | $938M | $328M | $313M | $301M | $232M | $251M | $49M | $86M | $49M | |
| Shares Outstanding | 160,980,024 | 110,461,729 | 86,124,249 | 69,893,434 | 43,805,922 | 32,347,905 | 7,665,763 | 30,057,970 | 10,201,690 |
现金流 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $2M | $2M | $800.0K | $147.0K | $720.0K | $1M | $1M | $1M | |
| Stock-based Comp | $46M | $40M | $31M | $18M | $12M | $6M | $3M | $3M | $1M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Restructuring | · | · | · | · | · | $4M | · | · | · | |
| Operating Cash Flow | $-264M | $-208M | $-154M | $-119M | $-59M | $-36M | $-42M | $-32M | $-26M | |
| CapEx | $2M | $573.0K | $3M | $7M | $2M | · | $33.0K | $549.0K | $912.0K | |
| Investing Cash Flow | $-400M | $38M | $-98M | $-125M | $-2M | $8M | $23M | $-11M | $14M | |
| Debt Issued | $49M | $0 | $0 | · | · | · | · | · | · | |
| Net Debt Issued | $49M | · | · | · | · | · | · | · | · | |
| Stock Issued | · | $0 | $162M | $0 | $0 | $25M | $108.0K | $609.0K | $60.0K | |
| Net Stock Activity | · | $0 | $162M | · | · | $25M | $108.0K | $609.0K | · | |
| Financing Cash Flow | $878M | $214M | $164M | $164M | $38M | $232M | $108.0K | $70M | $-729.0K | |
| Net Change in Cash | $214M | $45M | $-88M | $-80M | $-23M | $205M | $-18M | $27M | $-13M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-266M | $-208M | $-156M | $-126M | $-60M | · | $-42M | $-33M | · |
盈利能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -1044.3% | -143.0% | -369.9% | · | |
| Net Margin | · | · | · | · | · | -950.4% | -141.5% | -354.8% | · | |
| EBITDA Margin | · | · | · | · | · | -1044.3% | -143.0% | -369.9% | · | |
| ROA | -52.0% | -79.8% | -62.6% | -52.6% | -29.9% | -49.8% | -47.0% | -51.1% | · | |
| ROE | -83.1% | -89.6% | -68.6% | -51.4% | -35.1% | -70.4% | -105.4% | -54.1% | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.2 | 5.3 | 7.1 | 9.9 | 13.0 | 18.7 | 3.1 | 3.2 | · | |
| Quick Ratio | 4.9 | 1.8 | 1.4 | 5.2 | 12.9 | 18.5 | 3.0 | 3.2 | · |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.1 | 0.3 | 0.1 | · | |
| Receivables Turnover | · | · | · | · | · | · | 12.3 | 7.8 | · |
估值 (TTM) 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $23M | $23M | $23M | $23M | $23M | $8M | $22M | $10M | · | |
| Net Income TTM | $-329M | $-256M | $-192M | $-140M | $-72M | $-75M | $-32M | $-35M | · | |
| Market Cap | $5.72B | $862M | $506M | $808M | $376M | $363M | $88M | $529M | · | |
| P/E | -16.4 | -4.0 | -3.0 | -6.7 | -4.6 | -10.7 | -2.7 | -11.0 | · | |
| P/S | 246.9 | 37.2 | 21.9 | 34.9 | 16.2 | 46.2 | 3.9 | 54.3 | · | |
| P/B | 9.0 | 3.4 | 2.0 | 3.2 | 1.8 | 1.5 | 2.8 | 8.8 | · | |
| P / Tangible Book | 9.0 | 3.4 | 2.0 | 3.2 | 1.8 | 1.5 | · | · | · | |
| P / Cash Flow | -21.6 | -4.1 | -3.3 | -6.8 | -6.4 | -10.1 | -2.1 | -16.3 | · | |
| P / FCF | -21.5 | -4.1 | -3.2 | -6.4 | -6.2 | · | -2.1 | -16.0 | · | |
| Earnings Yield | -6.1% | -24.9% | -33.0% | -15.0% | -21.8% | -9.3% | -36.5% | -9.1% | · |
损益表 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $71M | $75M | $76M | $69M | $62M | $63M | $62M | $64M | $54M | $53M | $49M | $50M | $39M | $36M | $37M | $30M | |
| SG&A Expense | $32M | $28M | $24M | $14M | $13M | $12M | $12M | $12M | $10M | $10M | $10M | $9M | $8M | $7M | $7M | $7M | |
| Operating Expenses | $103M | $104M | $99M | $83M | $76M | $75M | $74M | $75M | $64M | $62M | $58M | $60M | $47M | $43M | $44M | $37M | |
| Operating Income | $-103M | $-104M | $-99M | $-83M | $-76M | $-75M | $-74M | $-75M | $-64M | $-62M | $-58M | $-60M | $-47M | $-43M | $-44M | $-37M | |
| Interest Income | $7M | $8M | $5M | $4M | $2M | $3M | $4M | $5M | $5M | $4M | $4M | $4M | $3M | $2M | $2M | $2M | |
| Other Non-op | $-11.0K | $-140.0K | $-6.0K | $-3.0K | $-6.0K | $-5.0K | $2M | $1.0K | $44.0K | $-1.0K | $-7.0K | $0 | $268.0K | $682.0K | $-1M | $2M | |
| Net Income | $-96M | $-97M | $-102M | $-81M | $-74M | $-72M | $-68M | $-71M | $-59M | $-58M | $-54M | $-55M | $-44M | $-39M | $-40M | $-35M | |
| EPS (Basic) | $-0.52 | $-0.53 | $-0.61 | $-0.50 | $-0.53 | $-0.52 | $-0.50 | $-0.52 | $-0.43 | $-0.49 | $-0.16 | $-0.64 | $-0.59 | $-0.55 | $0.16 | $-0.50 | |
| EPS (Diluted) | $-0.52 | $-0.53 | $-0.61 | $-0.50 | $-0.53 | $-0.52 | $-0.50 | $-0.52 | $-0.43 | $-0.49 | $-0.16 | $-0.64 | $-0.59 | $-0.55 | $0.16 | $-0.50 | |
| Shares (Basic) | 171,005,468 | 162,194,778 | -236,424,771 | 137,550,159 | 114,466,080 | 113,307,940 | -200,353,658 | 110,165,580 | 99,240,030 | 94,804,659 | -151,996,228 | 86,165,951 | 74,753,269 | 70,734,950 | -105,331,505 | 69,576,359 | |
| Shares (Diluted) | 171,005,468 | 162,194,778 | -236,424,771 | 137,550,159 | 114,466,080 | 113,307,940 | -200,353,658 | 110,165,580 | 99,240,030 | 94,804,659 | -151,996,228 | 86,165,951 | 74,753,269 | 70,734,950 | -105,331,505 | 69,576,359 | |
| EBITDA | $-103M | $-104M | · | $-83M | $-76M | $-75M | · | $-75M | $-64M | $-62M | · | $-60M | $-47M | $-43M | · | $-37M |
资产负债表 21
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $181M | $241M | $312M | $125M | $128M | $126M | $98M | $97M | $88M | $216M | · | $87M | $214M | $161M | · | $141M | |
| Prepaid Expense | $13M | $11M | $10M | $6M | $7M | $7M | $9M | $6M | $7M | $6M | · | $7M | $5M | $5M | · | $6M | |
| Current Assets | $805M | $878M | $910M | $397M | $245M | $253M | $296M | $342M | $370M | $442M | · | $286M | $335M | $226M | · | $296M | |
| PP&E (Net) | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $7M | $7M | $8M | · | $9M | $9M | $9M | · | $7M | |
| PP&E (Gross) | · | · | $14M | · | · | · | $13M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $9M | · | · | · | $6M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $2M | $3M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | · | $5M | |
| Total Assets | $835M | $903M | $938M | $426M | $275M | $284M | $328M | $384M | $430M | $476M | · | $355M | $392M | $263M | · | $332M | |
| Accounts Payable | $7M | $14M | $10M | $16M | $17M | $14M | $12M | $15M | $9M | $16M | · | $10M | $7M | $4M | · | $4M | |
| Current Liabilities | $59M | $58M | $64M | $62M | $58M | $49M | $56M | $53M | $40M | $37M | · | $35M | $26M | $21M | · | $24M | |
| Capital Leases | $19M | $14M | $14M | $15M | $15M | $15M | $16M | $16M | $17M | $17M | · | $18M | $18M | $19M | · | $18M | |
| Other Non-current Liabilities | $90.0K | $62.0K | $33.0K | $2M | $2M | $5.0K | $0 | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $302M | $295M | $301M | $123M | $120M | $65M | $72M | $69M | $57M | $54M | · | $53M | $44M | $40M | · | $42M | |
| Long-term Debt | $223M | $223M | $223M | $44M | $44M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | · | · | $44M | $44M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $171.0K | $171.0K | $161.0K | $141.0K | $114.0K | $114.0K | $110.0K | $110.0K | $109.0K | $96.0K | · | $86.0K | $85.0K | $71.0K | · | $70.0K | |
| Retained Earnings | $-1.38B | $-1.29B | $-1.19B | $-1.09B | $-1.00B | $-931M | $-859M | $-792M | $-721M | $-662M | · | $-549M | $-494M | $-450M | · | $-372M | |
| AOCI | $-770.0K | $-415.0K | $355.0K | $208.0K | $13.0K | $164.0K | $447.0K | $896.0K | $-192.0K | $-39.0K | · | $-172.0K | $-97.0K | $16.0K | · | $-163.0K | |
| Stockholders' Equity | $532M | $608M | $636M | $302M | $155M | $219M | $256M | $315M | $373M | $422M | $258M | $303M | $348M | $224M | $256M | $290M | |
| Liabilities + Equity | $835M | $903M | $938M | $426M | $275M | $284M | $328M | $384M | $430M | $476M | · | $355M | $392M | $263M | · | $332M | |
| Shares Outstanding | 171,598,409 | 170,773,803 | 160,980,024 | 139,827,662 | 113,928,492 | 113,856,454 | 110,461,729 | 110,458,249 | 109,343,224 | 95,613,396 | · | 86,124,249 | 85,334,165 | 70,946,790 | · | 69,857,972 |
现金流 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $741.0K | $626.0K | $664.0K | $641.0K | $655.0K | $640.0K | $675.0K | $620.0K | $606.0K | $599.0K | $628.0K | $581.0K | $562.0K | $529.0K | $378.0K | $256.0K | |
| Stock-based Comp | $17M | $17M | $16M | $11M | $10M | $10M | $10M | $10M | $10M | $9M | $9M | $9M | $7M | $6M | $5M | $5M | |
| Operating Cash Flow | $-77M | $-87M | $-79M | $-64M | $-55M | $-67M | $-61M | $-52M | $-43M | $-53M | $-44M | $-38M | $-32M | $-40M | $-29M | $-34M | |
| CapEx | $370.0K | $449.0K | $811.0K | $65.0K | $131.0K | $547.0K | $75.0K | $280.0K | $148.0K | $70.0K | $315.0K | $121.0K | $1M | $1M | $2M | $3M | |
| Investing Cash Flow | $14M | $-36M | $-323M | $-155M | $9M | $69M | $62M | $60M | $-85M | $1M | $10M | $-91M | $-78M | $60M | $28M | $-152M | |
| Debt Issued | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $0 | · | · | · | $-170.0K | · | · | · | · | |
| Financing Cash Flow | $3M | $53M | $589M | $217M | $47M | $25M | $26.0K | $624.0K | $-256.0K | $214M | $0 | $1M | $162M | $445.0K | $315.0K | $990.0K | |
| Net Change in Cash | $-60M | $-71M | $187M | $-2M | $2M | $28M | $1M | $9M | $-128M | $163M | $-34M | $-128M | $52M | $21M | $-682.0K | $-185M | |
| Free Cash Flow | · | $-87M | · | · | · | $-67M | · | · | · | $-53M | · | · | · | $-41M | · | · |
盈利能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -17.4% | -16.4% | · | -20.0% | -20.9% | -18.9% | · | -19.1% | -14.3% | -15.8% | · | -16.1% | -11.6% | -16.4% | · | -12.8% | |
| ROE | -28.1% | -23.5% | · | -26.2% | -27.8% | -22.4% | · | -22.9% | -16.3% | -18.1% | · | -18.7% | -13.2% | -18.8% | · | -14.4% |
流动性与偿付能力 4
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.6 | 15.1 | · | 6.4 | 4.2 | 5.1 | · | 6.4 | 9.2 | 12.0 | · | 8.2 | 13.0 | 10.7 | · | 12.6 | |
| Quick Ratio | 3.1 | 4.2 | · | 2.0 | 2.2 | 2.6 | · | 1.8 | 2.2 | 5.9 | · | 2.5 | 8.3 | 7.6 | · | 6.0 | |
| Debt / Equity | · | · | · | 0.1 | 0.3 | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.1 | 0.3 | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $23M | $23M | · | $23M | $23M | $23M | · | $23M | $23M | $23M | · | $23M | $23M | $23M | · | $23M | |
| Net Income TTM | $-348M | $-324M | · | $-297M | $-275M | $-260M | · | $-243M | $-217M | $-196M | · | $-173M | $-153M | $-139M | · | $-120M | |
| Market Cap | $6.64B | $6.57B | · | $2.01B | $818M | $682M | · | $1.19B | $922M | $643M | · | $840M | $1.01B | $766M | · | $1.04B | |
| Enterprise Value | · | · | · | $1.93B | $734M | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -18.6 | -18.5 | · | -6.9 | -3.6 | -3.1 | · | -5.2 | -3.9 | -3.0 | · | -4.3 | -5.0 | -4.4 | · | -6.3 | |
| P/S | 286.8 | 283.8 | · | 86.7 | 35.3 | 29.4 | · | 51.5 | 39.8 | 27.7 | · | 36.3 | 43.6 | 33.1 | · | 45.0 | |
| P/B | 12.5 | 10.8 | · | 6.6 | 5.3 | 3.1 | · | 3.8 | 2.5 | 1.5 | · | 2.8 | 2.9 | 3.4 | · | 3.6 | |
| P / Tangible Book | 12.5 | 10.8 | · | 6.6 | 5.3 | 3.1 | · | 3.8 | 2.5 | 1.5 | · | 2.8 | 2.9 | 3.4 | · | 3.6 | |
| P / Cash Flow | · | -75.7 | · | · | · | -10.3 | · | · | · | -12.2 | · | · | · | -19.4 | · | · | |
| P / FCF | · | -75.3 | · | · | · | -10.2 | · | · | · | -12.2 | · | · | · | -18.8 | · | · | |
| EV / EBITDA | · | · | · | -23.1 | -9.7 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | 83.2 | 31.7 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -5.4% | -5.4% | · | -14.4% | -27.9% | -32.7% | · | -19.3% | -25.5% | -33.8% | · | -23.4% | -19.9% | -22.6% | · | -15.9% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 净收入 | $-329M | $-256M | $-192M | $-140M | $-72M |
| 稀释后每股收益 (EPS) | $-2.16 | $-1.94 | $-1.94 | $-1.73 | $-1.87 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 14.2 | 5.3 | 7.1 | 9.9 | 13.0 |
| 速动比率 | 4.9 | 1.8 | 1.4 | 5.2 | 12.9 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-266M | $-208M | $-156M | $-126M | $-60M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 342 家申报者 · $5.5B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 71 (-4 与上一季度对比) | 40 (+6 与上一季度对比) | 119 (+7 与上一季度对比) | 93 (+10 与上一季度对比) | +18.6M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| FMR LLC | $868722546 | 22447611 | 15.68% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $312402306 | 8072411 | 5.64% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $286857171 | 7412330 | 5.18% | 股份 |
| STATE STREET CORP | $269542365 | 6964919 | 4.87% | 股份 |
| Fairmount Funds Management LLC | $212982277 | 5503418 | 3.84% | 股份 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $193736225 | 5006104 | 3.50% | 股份 |
| TCG Crossover Management, LLC | $187866673 | 4854436 | 3.39% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $150424045 | 3885979 | 2.72% | 股份 |
| Kynam Capital Management, LP | $141916654 | 3667097 | 2.56% | 股份 |
| Polar Capital Holdings Plc | $125113424 | 3232905 | 2.26% | 股份 |
| Commodore Capital LP | $118035000 | 3050000 | 2.13% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $108741040 | 2809846 | 1.96% | 股份 |
| Woodline Partners LP | $100742369 | 2603162 | 1.82% | 股份 |
| Pictet Asset Management Holding SA | $92634023 | 2393515 | 1.67% | 股份 |
| Octagon Capital Advisors LP | $90945000 | 2350000 | 1.64% | 股份 |
| RTW INVESTMENTS, LP | $89359113 | 2309021 | 1.61% | 股份 |
| Candriam S.C.A. | $80742121 | 2088369 | 1.46% | 股份 |
| Deep Track Capital, LP | $77400000 | 2000000 | 1.40% | 股份 |
| Siren, L.L.C. | $71954097 | 1859279 | 1.30% | 股份 |
| ORBIMED ADVISORS LLC | $65066310 | 1681300 | 1.17% | 股份 |
| Venrock Adviser, LLC | $63551824 | 1642166 | 1.15% | 股份 |
| GOLDMAN SACHS GROUP INC | $63052788 | 1629271 | 1.14% | 股份 |
| EMERALD ADVISERS, LLC | $62048445 | 1603319 | 1.12% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $56087910 | 1449300 | 1.01% | 股份 |
| Assenagon Asset Management S.A. | $55795957 | 1441756 | 1.01% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $55455537 | 1432957 | 1.00% | 股份 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $49563361 | 1280707 | 0.89% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $46962837 | 1213510 | 0.85% | 股份 |
| Elmind Capital, LP | $45307638 | 1170740 | 0.82% | 股份 |
| FRED ALGER MANAGEMENT, LLC | $41518521 | 1072830 | 0.75% | 股份 |
| Sofinnova Investments, Inc. | $40060228 | 1035148 | 0.72% | 股份 |
| EMERALD MUTUAL FUND ADVISERS TRUST | $39914329 | 1031378 | 0.72% | 股份 |
| BANK OF AMERICA CORP /DE/ | $38680534 | 999497 | 0.70% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $38551702 | 996168 | 0.70% | 股份 |
| Balyasny Asset Management L.P. | $36952424 | 954843 | 0.67% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $35128454 | 907712 | 0.63% | 股份 |
| Logos Global Management LP | $34830000 | 900000 | 0.63% | 股份 |
| Squadron Capital Management LLC | $33475500 | 865000 | 0.60% | 股份 |
| CITADEL ADVISORS LLC | $32883158 | 849694 | 0.59% | 股份 |
| D. E. Shaw & Co., Inc. | $29941106 | 773672 | 0.54% | 股份 |
| Point72 Asset Management, L.P. | $28800347 | 744195 | 0.52% | 股份 |
| MARSHALL WACE, LLP | $27328122 | 706153 | 0.49% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $26812328 | 692825 | 0.48% | 股份 |
| J. Goldman & Co LP | $24690368 | 637994 | 0.45% | 股份 |
| First Turn Management, LLC | $23308275 | 602281 | 0.42% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $23119380 | 597400 | 0.42% | 买入期权 |
| ALLIANCEBERNSTEIN L.P. | $22042992 | 572694 | 0.40% | 股份 |
| Rock Springs Capital Management LP | $19965988 | 515917 | 0.36% | 股份 |
| Redmile Group, LLC | $19478523 | 503321 | 0.35% | 股份 |
| DIADEMA PARTNERS LP | $19104797 | 493664 | 0.34% | 股份 |
| Eversept Partners, LP | $18972094 | 490235 | 0.34% | 股份 |
| SPHERA FUNDS MANAGEMENT LTD. | $17776458 | 459340 | 0.32% | 股份 |
| Ensign Peak Advisors, Inc | $17697587 | 457302 | 0.32% | 股份 |
| Affinity Asset Advisors, LLC | $17415000 | 450000 | 0.31% | 股份 |
| BlackRock, Inc. | $16916738 | 437125 | 0.31% | 股份 |
| Patient Square Capital LP | $16447500 | 425000 | 0.30% | 股份 |
| SEGALL BRYANT & HAMILL, LLC | $16300711 | 421207 | 0.29% | 股份 |
| AMERIPRISE FINANCIAL INC | $16177723 | 418029 | 0.29% | 股份 |
| Defilade Capital Management, L.P. | $15226167 | 393441 | 0.27% | 股份 |
| Aberdeen Group plc | $15218156 | 393234 | 0.27% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $15189000 | 392484 | 0.27% | 股份 |
| Ikarian Capital, LLC | $14322251 | 370084 | 0.26% | 股份 |
| KENNEDY CAPITAL MANAGEMENT LLC | $13691673 | 353790 | 0.25% | 股份 |
| SUPERSTRING CAPITAL MANAGEMENT LP | $13285091 | 343284 | 0.24% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $12861326 | 332334 | 0.23% | 股份 |
| Burkehill Global Management, LP | $12577500 | 325000 | 0.23% | 股份 |
| FEDERATED HERMES, INC. | $10951287 | 282979 | 0.20% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $10799854 | 279066 | 0.19% | 股份 |
| Alyeska Investment Group, L.P. | $10636656 | 274849 | 0.19% | 股份 |
| NEUBERGER BERMAN GROUP LLC | $9918346 | 256288 | 0.18% | 股份 |
| Parkman Healthcare Partners LLC | $9805226 | 253365 | 0.18% | 股份 |
| Evergreen Quality Fund GP, Ltd. | $9675000 | 250000 | 0.17% | 股份 |
| Swiss National Bank | $9535680 | 246400 | 0.17% | 股份 |
| Russell Investments Group, Ltd. | $8936487 | 230917 | 0.16% | 股份 |
| Susquehanna Portfolio Strategies, LLC | $8891519 | 229755 | 0.16% | 股份 |
| F/m Investments LLC | $8850226 | 228688 | 0.16% | 股份 |
| SEB Asset Management AB | $8827182 | 228093 | 0.16% | 股份 |
| PEREGRINE CAPITAL MANAGEMENT LLC | $8759745 | 226350 | 0.16% | 股份 |
| Boxer Capital Management, LLC | $8707500 | 225000 | 0.16% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $8673289 | 224116 | 0.16% | 股份 |
| Exome Asset Management LLC | $8147240 | 210523 | 0.15% | 股份 |
| RHUMBLINE ADVISERS | $8034456 | 207609 | 0.15% | 股份 |
| Integral Health Asset Management, LLC | $7740000 | 200000 | 0.14% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7472970 | 193100 | 0.13% | 卖出期权 |
| Pier Capital, LLC | $7312404 | 188951 | 0.13% | 股份 |
| HighVista Strategies LLC | $7305786 | 188780 | 0.13% | 股份 |
| Jefferies Financial Group Inc. | $7281753 | 188159 | 0.13% | 股份 |
| Fisher Asset Management, LLC | $7154661 | 184875 | 0.13% | 股份 |
| Caption Management, LLC | $7124670 | 184100 | 0.13% | 买入期权 |
| SummitTX Capital, L.P. | $6955706 | 179734 | 0.13% | 股份 |
| OSTERWEIS CAPITAL MANAGEMENT INC | $6659690 | 172085 | 0.12% | 股份 |
| CITIGROUP INC | $6611315 | 170835 | 0.12% | 股份 |
| Qube Research & Technologies Ltd | $6547963 | 169198 | 0.12% | 股份 |
| Schonfeld Strategic Advisors LLC | $6544672 | 169113 | 0.12% | 股份 |
| Man Group plc | $6496105 | 167858 | 0.12% | 股份 |
| VOYA INVESTMENT MANAGEMENT LLC | $6491112 | 167729 | 0.12% | 股份 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $6174392 | 159545 | 0.11% | 股份 |
| Nuveen, LLC | $6140258 | 158663 | 0.11% | 股份 |
| Atika Capital Management LLC | $6130970 | 158423 | 0.11% | 股份 |
| WELLS FARGO & COMPANY/MN | $6096256 | 157526 | 0.11% | 股份 |
公司内部人士 25 位内幕人士 · 11 位高管 · 13 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Andrew R Robbins | President and CEO | 2026年5月19日 G | 160000 | 0 | 0 | $0 |
| Charles Wilson | Chief Executive Officer | 2019年3月1日 A | — | 0 | 0 | $0 |
| John L. Green | Chief Financial Officer | 2025年12月26日 S | 131834 | 0 | 1 | $-2978360 |
| Matthew Scott Osborne | Chief Financial Officer | 2020年2月11日 A | — | 0 | 0 | $0 |
| John Edward Robinson | Chief Scientific Officer | 2025年12月26日 S | 140002 | 0 | 1 | $-3486600 |
| Jessica Sachs | Chief Medical Officer | 2025年12月26日 S | 133938 | 0 | 1 | $-3198245 |
| Evan Kearns | Chief Legal Officer | 2025年12月26日 S | 109398 | 0 | 1 | $-2515500 |
| Cole Pinnow | Chief Commercial Officer | 2025年12月17日 A | 216650 | 0 | 0 | $0 |
| Geoffrey Hodge | Chief Technical Officer | 2020年2月11日 A | — | 0 | 0 | $0 |
| Seth Ettenberg | Chief Scientific Officer | 2020年2月11日 A | 0 | 0 | 0 | $0 |
| Michael Vasconcelles | Chief Medical Officer | 2019年3月1日 A | — | 0 | 0 | $0 |
| Karen Jean Ferrante | 董事 | 2026年7月1日 A | — | 0 | 0 | $0 |
| Christopher W. Cain | 董事 | 2026年6月9日 A | — | 0 | 0 | $0 |
| Todd Shegog | 董事 | 2026年6月9日 A | — | 0 | 0 | $0 |
| Matthew Ros | 董事 | 2026年6月9日 A | — | 0 | 0 | $0 |
| Peter Harwin | 董事 | 2026年6月9日 A | — | 0 | 0 | $0 |
| Arlene Morris | 董事 | 2026年6月9日 A | — | 0 | 0 | $0 |
| Fairmount Funds Management LLC | 董事 | 2026年3月31日 C | 5503418 | 0 | 2 | $-370020000 |
| Jorn Aldag | 董事 | 2020年7月1日 A | — | 0 | 0 | $0 |
| Bruce Booth | 董事 | 2020年7月1日 A | 3361535 | 0 | 0 | $0 |
| Liam Ratcliffe | 董事 | 2019年6月14日 A | 897773 | 0 | 0 | $0 |
| Robert J Perez | 董事 | 2019年6月14日 A | — | 0 | 0 | $0 |
| Dario Campana | 10% 所有者 | 2020年5月12日 S | 3095114 | 0 | 0 | $0 |
| FIL Ltd | — | 2018年4月3日 C | 1138274 | 0 | 0 | $0 |
| FMR LLC | — | 2018年4月3日 C | 23240 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II GP LLC ×11 申报 | 2026年3月31日 | 8.60% | 修订 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 46 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 7.53% | 226142 NS | 2026年5月31日 | N-PORT |
| CANC · Tema ETF Trust | 4.10% | 206419 NS | 2026年5月31日 | N-PORT |
| FMED · Fidelity Covington Trust | 2.85% | 33428 NS | 2026年5月31日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.93% | 134554 NS | 2026年4月30日 | N-PORT |
| BBC · ETFis Series Trust I | 0.63% | 6554 NS | 2026年4月30日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.49% | 9297 SH | 2026年8月8日 | 每日 |
| IBB · iShares Trust | 0.47% | 1079378 SH | 2026年8月8日 | 每日 |
| IWO · iShares Trust | 0.43% | 1511513 SH | 2026年8月8日 | 每日 |
| ESSC · Strategy Shares | 0.42% | 3026 NS | 2026年4月30日 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.38% | 178467 SH | 2026年8月8日 | 每日 |
| BIB · ProShares Trust | 0.28% | 6002 NS | 2026年5月31日 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0.25% | 89450 NS | 2026年4月30日 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.22% | 45155 NS | 2026年4月30日 | N-PORT |
| IWM · iShares Trust | 0.22% | 4223751 SH | 2026年8月8日 | 每日 |
| ISCG · iShares Trust | 0.20% | 48762 SH | 2026年8月8日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.20% | 959613 SH | 2026年8月8日 | 每日 |
| BKSE · BNY Mellon ETF Trust | 0.18% | 4161 NS | 2026年4月30日 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.17% | 85339 SH | 2026年8月8日 | 每日 |
| RSSL · Global X Funds | 0.16% | 62036 NS | 2026年4月30日 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.13% | 2363019 SH | 2026年8月8日 | 每日 |
| ITWO · ProShares Trust | 0.13% | 6734 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.11% | 738864 NS | 2026年5月31日 | N-PORT |
| ISCB · iShares Trust | 0.10% | 6956 SH | 2026年8月8日 | 每日 |
| ESML · iShares Trust | 0.08% | 57512 SH | 2026年8月8日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.08% | 3722357 SH | 2026年8月8日 | 每日 |
| UWM · ProShares Trust | 0.07% | 5268 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.07% | 1958933 SH | 2026年8月8日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.07% | 368585 SH | 2026年8月8日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.06% | 43571 SH | 2026年8月8日 | 每日 |
| GSSC · Goldman Sachs ETF Trust | 0.06% | 17403 NS | 2026年5月31日 | N-PORT |
| URTY · ProShares Trust | 0.05% | 5326 NS | 2026年5月31日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.05% | 147 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.05% | 38351 NS | 2026年4月30日 | N-PORT |
| WSML · iShares Trust | 0.05% | 7228 SH | 2026年8月8日 | 每日 |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.03% | 5488 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.02% | 134 NS | 2026年5月31日 | N-PORT |
| SMLF · iShares Trust | 0.02% | 18861 SH | 2026年8月8日 | 每日 |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 42596 NS | 2026年5月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 5158077 SH | 2026年8月8日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | 0.01% | 133924 SH | 2026年8月8日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 13697 SH | 2026年8月8日 | 每日 |
| ESGV · VANGUARD WORLD FUND | 0.01% | 36815 SH | 2026年8月8日 | 每日 |
| ITOT · iShares Trust | 0.01% | 228068 SH | 2026年8月8日 | 每日 |
| TILT · FlexShares Trust | 0.01% | 5513 NS | 2026年4月30日 | N-PORT |
| IWV · iShares Trust | 0.01% | 44292 SH | 2026年8月8日 | 每日 |
| SCHB · SCHWAB STRATEGIC TRUST | 0.01% | 92899 NS | 2026年5月31日 | N-PORT |